BACKGROUND AND AIMS: Hepatitis C virus (HCV)-induced chronic inflammation may induce oxidative stress which could compromise the repair of damaged DNA, rendering cells more susceptible to spontaneous or mutagen-induced alterations, the underlying cause of liver cirrhosis and hepatocellular carcinoma. In the current study we examined the induction of reactive oxygen species (ROS) resulting from HCV infection and evaluated its effect on the host DNA damage and repair machinery. METHODS: HCV infected human hepatoma cells were analyzed to determine (i) ROS, (ii) 8-oxoG and (iii) DNA glycosylases NEIL1, NEIL2, OGG1. Liver biopsies were analyzed for NEIL1. RESULTS: Human hepatoma cells infected with HCV JFH-1 showed 30-60-fold increases in ROS levels compared to uninfected cells. Levels of the oxidatively modified guanosine base 8-oxoguanine (8-oxoG) were significantly increased sixfold in the HCV-infected cells. Because DNA glycosylases are the enzymes that remove oxidized nucleotides, their expression in HCV-infected cells was analyzed. NEIL1 but not OGG1 or NEIL2 gene expression was impaired in HCV-infected cells. In accordance, we found reduced glycosylase (NEIL1-specific) activity in HCV-infected cells. The antioxidant N-acetyl cystein (NAC) efficiently reversed the NEIL1 repression by inhibiting ROS induction by HCV. NEIL1 expression was also partly restored when virus-infected cells were treated with interferon (IFN). HCV core and to a lesser extent NS3-4a and NS5A induced ROS, and downregulated NEIL1 expression. Liver biopsy specimens showed significant impairment of NEIL1 levels in HCV-infected patients with advanced liver disease compared to patients with no disease. CONCLUSION: Collectively, the data indicate that HCV induction of ROS and perturbation of NEIL1 expression may be mechanistically involved in progression of liver disease and suggest that antioxidant and antiviral therapies can reverse these deleterious effects of HCV in part by restoring function of the DNA repair enzyme/s.
BACKGROUND AND AIMS: Hepatitis C virus (HCV)-induced chronic inflammation may induce oxidative stress which could compromise the repair of damaged DNA, rendering cells more susceptible to spontaneous or mutagen-induced alterations, the underlying cause of liver cirrhosis and hepatocellular carcinoma. In the current study we examined the induction of reactive oxygen species (ROS) resulting from HCV infection and evaluated its effect on the host DNA damage and repair machinery. METHODS:HCV infected human hepatoma cells were analyzed to determine (i) ROS, (ii) 8-oxoG and (iii) DNA glycosylases NEIL1, NEIL2, OGG1. Liver biopsies were analyzed for NEIL1. RESULTS:Humanhepatoma cells infected with HCV JFH-1 showed 30-60-fold increases in ROS levels compared to uninfected cells. Levels of the oxidatively modified guanosine base 8-oxoguanine (8-oxoG) were significantly increased sixfold in the HCV-infected cells. Because DNA glycosylases are the enzymes that remove oxidized nucleotides, their expression in HCV-infected cells was analyzed. NEIL1 but not OGG1 or NEIL2 gene expression was impaired in HCV-infected cells. In accordance, we found reduced glycosylase (NEIL1-specific) activity in HCV-infected cells. The antioxidant N-acetyl cystein (NAC) efficiently reversed the NEIL1 repression by inhibiting ROS induction by HCV. NEIL1 expression was also partly restored when virus-infected cells were treated with interferon (IFN). HCV core and to a lesser extent NS3-4a and NS5A induced ROS, and downregulated NEIL1 expression. Liver biopsy specimens showed significant impairment of NEIL1 levels in HCV-infected patients with advanced liver disease compared to patients with no disease. CONCLUSION: Collectively, the data indicate that HCV induction of ROS and perturbation of NEIL1 expression may be mechanistically involved in progression of liver disease and suggest that antioxidant and antiviral therapies can reverse these deleterious effects of HCV in part by restoring function of the DNA repair enzyme/s.
Authors: Keigo Machida; Kevin T-H Cheng; Chao-Kuen Lai; King-Song Jeng; Vicky M-H Sung; Michael M C Lai Journal: J Virol Date: 2006-07 Impact factor: 5.103
Authors: Errol C Friedberg; Andres Aguilera; Martin Gellert; Philip C Hanawalt; John B Hays; Alan R Lehmann; Tomas Lindahl; Noel Lowndes; Alain Sarasin; Richard D Wood Journal: DNA Repair (Amst) Date: 2006-08-13
Authors: Vladimir Vartanian; Brian Lowell; Irina G Minko; Thomas G Wood; Jeffrey D Ceci; Shakeeta George; Scott W Ballinger; Christopher L Corless; Amanda K McCullough; R Stephen Lloyd Journal: Proc Natl Acad Sci U S A Date: 2006-01-30 Impact factor: 11.205
Authors: Leonard B Seeff; Teresa M Curto; Gyongyi Szabo; Gregory T Everson; Herbert L Bonkovsky; Jules L Dienstag; Mitchell L Shiffman; Karen L Lindsay; Anna S F Lok; Adrian M Di Bisceglie; William M Lee; Marc G Ghany Journal: Hepatology Date: 2008-02 Impact factor: 17.425
Authors: Aditi Das; Istvan Boldogh; Jae Wan Lee; Jeanine A Harrigan; Muralidhar L Hegde; Jason Piotrowski; Nadja de Souza Pinto; William Ramos; Marc M Greenberg; Tapas K Hazra; Sankar Mitra; Vilhelm A Bohr Journal: J Biol Chem Date: 2007-07-03 Impact factor: 5.157
Authors: Sampa Pal; Margaret C Shuhart; Lisa Thomassen; Scott S Emerson; Tao Su; Nathan Feuerborn; John Kae; David R Gretch Journal: J Virol Date: 2006-03 Impact factor: 5.103
Authors: Harini Sampath; Ayesha K Batra; Vladimir Vartanian; J Russ Carmical; Deborah Prusak; Irena B King; Brian Lowell; Lauriel F Earley; Thomas G Wood; Daniel L Marks; Amanda K McCullough; Lloyd R Stephen Journal: Am J Physiol Endocrinol Metab Date: 2011-02-01 Impact factor: 4.310
Authors: Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi Journal: World J Hepatol Date: 2013-10-27
Authors: Donna N Douglas; Christopher Hao Pu; Jamie T Lewis; Rakesh Bhat; Anwar Anwar-Mohamed; Michael Logan; Garry Lund; William R Addison; Richard Lehner; Norman M Kneteman Journal: J Biol Chem Date: 2015-12-01 Impact factor: 5.157
Authors: Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli Journal: World J Gastroenterol Date: 2016-01-28 Impact factor: 5.742